BioMaTek ApS: Financial statements 2022
CVR: 38928864
Source: annual report 2022, Danish Business Authority
01/07/2021 – 30/06/2022
BioMaTek ApS (CVR 38928864) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 100,916 and a net result of DKK -118,048 compared with DKK -7,141 the year before. That is a decrease of 58.7% compared with the year before. Equity in the 2022 report amounted to DKK 62,322. The solvency ratio was 7.4%.
- Gross Profit
- DKK 100,916
- Profit/Loss
- DKK -118,048
- Equity
- DKK 62,322
- Total Assets
- DKK 836,563
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 101 t. | -118 t. | 62 t. | - |
| 2021 | - | 245 t. | -7 t. | 180 t. | - |
| 2020 | - | 368 t. | 48 t. | 188 t. | - |
| 2019 | - | 51 t. | -13 t. | 139 t. | - |
Official annual report
Keep an eye on BioMaTek ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 4, 2022, Torben Flye Jensen has stepped down as director of BioMaTek ApS.
About BioMaTek ApS
BioMaTek ApS is a Danish company of the type Anpartsselskab based in Bedsted Thy, founded in 2017. The company is in liquidation. The company is registered under the industry Installation af isolering. The management consists of Jacob Morten Schousgaard. The company is owned by K.Y.M. ApS, TVT Group ApS and HN2024 Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 305,673 and a net result of DKK 6,138. Equity in the 2025 report amounted to DKK 18,905.